gdc

Multiple Myeloma

My Journey with Multiple Myeloma and the New Opportunities Through the MMJP Program
Multiple Myeloma
Dentist John Killip presents his journey with multiple myeloma, which included using his professional skills to give himself a stem-cell injection as part of his transplant, and joining the MMJP program.
Immunotherapy Has Come to Multiple Myeloma
ImmunotherapyMultiple Myeloma
“We are continuing to learn about the ways the immune system interacts with difference types of cancer, including multiple myeloma,” said Dr. Pazdur of the FDA.
Living Life Fully with Multiple Myeloma
Multiple MyelomaPatient Stories
Yelak Biru, who was diagnosed with multiple myeloma at age 25, shares his inspiring story, including the top 3 lessons that helped him remain positive.
Finding Positive Spots in My Multiple Myeloma Journey
Multiple Myeloma
Saying a few good words about cancer may seem a daunting task. However, lately it has occurred to me that my journey with cancer has some bright spots. It all began on March 17, 2014. The day you learn you might have cancer is a date you never forget.
Multiple Myeloma
Multiple MyelomaSlideshowsWeb Exclusives
March is multiple myeloma month. Check out our slideshow on this cancer type.
Lack of Diversity in Clinical Trials Hurts Patients and Drug Development
Clinical TrialsMultiple Myeloma
Despite the great advances in cancer therapies, only a small proportion of patients with cancer participate in clinical trials today. This has a detrimental effect on the development of new cancer drugs.
Meeting of Hearts & Minds: Connecting Patients with Cancer Researchers
Cancer ResearchMultiple Myeloma
It’s quite common for patients with cancer to form strong bonds with their oncologists. But it’s not often that patients form connections with researchers, the very scientists who develop cancer therapies that help patients, especially patients facing cancer.
Patient Advocacy in Support of James Bond's Fight to Conquer Multiple Myeloma
Multiple MyelomaPatient Advocacy
The death-defying feats of James Bond were explored on an episode of the Lifetime network’s The Balancing Act. No, not that James Bond. Our James Bond didn’t hail from the UK’s Secret Service, but is an American who has been besieged by a foe as lethal as Dr. No or SMERSH–the rare blood cancer multiple myeloma.
Genetic Influences in Multiple Myeloma
Genetics & CancerMultiple Myeloma
Multiple myeloma is a type of blood cancer; the cause of this cancer is not yet known. Although it is not considered a hereditary cancer and does not run in families, many genetic factors, especially genetic alterations (mutations) and chromosome abnormalities, play a role in multiple myeloma, as in many other cancers.
African Americans Are at Increased Risk for Multiple Myeloma
Multiple Myeloma
Multiple myeloma is a rare blood cancer that causes white blood cells to over produce, preventing healthy blood cells to grow in the bone marrow. The abnormal cells develop into cancerous cells that affect the kidneys and other organs, and lead to bone problems and infections.
Page 4 of 10
Results 31 - 40 of 96

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country